Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hansi J Dean

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Nature Communications|December 17, 2021
Single dose of chimeric dengue-2/Zika vaccine candidate protects mice and non-human primates against Zika virusWhitney R Baldwin, Holli A Giebler, Janae L Stovall, et al.
Scientific Reports|February 28, 2020
Complete Protection in Macaques Conferred by Purified Inactivated Zika Vaccine: Defining a Correlate of ProtectionGinger Young, Kelly J Bohning, Melissa Zahralban-Steele, et al.
Journal of Virology|May 16, 2022
Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and FunctionIsamu Tsuji, Fue Vang, David Dominguez, et al.
The Journal of Infectious Diseases|June 30, 2022
Specificity and Breadth of the Neutralizing Antibody Response to a Live-Attenuated Tetravalent Dengue VaccineChristina R DeMaso, Lovkesh Karwal, Melissa Zahralban-Steele, et al.
The Journal of Infectious Diseases|May 26, 2018
Analyzing the Human Serum Antibody Responses to a Live Attenuated Tetravalent Dengue Vaccine CandidateJesica A Swanstrom, Sandra Henein, Jessica A Plante, et al.
Cell Reports|February 9, 2022
Transcriptome-wide changes in gene expression, splicing, and lncRNAs in response to a live attenuated dengue virus vaccineEun-Young Kim, Yan Che, Hansi J Dean, et al.
Scientific Reports|November 9, 2018
Purified Inactivated Zika Vaccine Candidates Afford Protection against Lethal Challenge in MiceWhitney R Baldwin, Jill A Livengood, Holli A Giebler, et al.
Journal of Virology|July 8, 2011
Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimenNicola Winstone, Aaron J Wilson, Gavin Morrow, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Nature Communications|December 17, 2021
Single dose of chimeric dengue-2/Zika vaccine candidate protects mice and non-human primates against Zika virusWhitney R Baldwin, Holli A Giebler, Janae L Stovall, et al.
Scientific Reports|February 28, 2020
Complete Protection in Macaques Conferred by Purified Inactivated Zika Vaccine: Defining a Correlate of ProtectionGinger Young, Kelly J Bohning, Melissa Zahralban-Steele, et al.
Journal of Virology|May 16, 2022
Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and FunctionIsamu Tsuji, Fue Vang, David Dominguez, et al.
The Journal of Infectious Diseases|June 30, 2022
Specificity and Breadth of the Neutralizing Antibody Response to a Live-Attenuated Tetravalent Dengue VaccineChristina R DeMaso, Lovkesh Karwal, Melissa Zahralban-Steele, et al.
The Journal of Infectious Diseases|May 26, 2018
Analyzing the Human Serum Antibody Responses to a Live Attenuated Tetravalent Dengue Vaccine CandidateJesica A Swanstrom, Sandra Henein, Jessica A Plante, et al.
Cell Reports|February 9, 2022
Transcriptome-wide changes in gene expression, splicing, and lncRNAs in response to a live attenuated dengue virus vaccineEun-Young Kim, Yan Che, Hansi J Dean, et al.
Scientific Reports|November 9, 2018
Purified Inactivated Zika Vaccine Candidates Afford Protection against Lethal Challenge in MiceWhitney R Baldwin, Jill A Livengood, Holli A Giebler, et al.
Journal of Virology|July 8, 2011
Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimenNicola Winstone, Aaron J Wilson, Gavin Morrow, et al.
Pageof 3